Related Experiment Video
Updated: Aug 31, 2025

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
Liver X receptor: a potential target in the treatment of atherosclerosis
Shreya R Savla1, Kedar S Prabhavalkar1, Lokesh K Bhatt1
1Department of Pharmacology, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, Mumbai, India.
Introduction:
Liver X receptors (LXRs) are master regulators of atherogenesis. Their anti-atherogenic potential has been attributed to their role in the inhibition of macrophage-mediated inflammation and promotion of reverse cholesterol transport. Owing to the significance of their anti-atherogenic potential, it is essential to develop and test new-generation LXR agonists, both synthetic and natural, to identify potential LXR-targeted therapeutics for the future.
Areas Covered:
This review describes the role of LXRs in atherosclerotic development, and provides a summary of LXR agonists and future directions for atherosclerosis research. We searched PubMed, Scopus, and Google Scholar for relevant reports, from last 10 years, using atherosclerosis, liver X receptor, and LXR agonist as keywords.
Expert Opinion:
LXRα has gained widespread recognition as a regulator of cholesterol homeostasis and expression of inflammatory genes. Further research using models of cell type-specific knockout and specific agonist-targeted LXR isoforms is warranted. Enthusiasm for therapeutic value of LXR agonists has been tempered due to LXRα-mediated induction of hepatic lipogenesis. LXRα agonism and LXRβ targeting, gut-specific inverse LXR agonists, investigations combining LXR agonists with other lipogenesis-mitigating agents, like IDOL antagonists and synthetic HDL, and targeting ABCA1, M2 macrophages, and LXRα phosphorylation remain as promising possibilities.
Insights
Liver X receptors (LXRs) regulate cholesterol and inflammation in atherosclerosis. New LXR agonists show therapeutic promise, but LXRα
Area of Science:
- Cardiovascular Research
- Molecular Biology
- Pharmacology
Background:
- Liver X receptors (LXRs) are key regulators of atherosclerosis, influencing macrophage inflammation and reverse cholesterol transport.
- Developing novel LXR agonists is crucial for identifying future therapeutic strategies against atherosclerosis.
Purpose of the Study:
- To review the role of LXRs in atherosclerotic development.
- To summarize current LXR agonists and explore future research directions in atherosclerosis.
Main Methods:
- Systematic literature search of PubMed, Scopus, and Google Scholar.
- Keywords used: atherosclerosis, liver X receptor, LXR agonist.
- Focus on research from the last 10 years.
Main Results:
- LXRα regulates cholesterol homeostasis and inflammatory gene expression.
- LXR agonists face challenges due to LXRα-induced hepatic lipogenesis.
- Research is exploring cell type-specific knockouts and isoform-specific agonists.
Conclusions:
- Targeting LXRα and LXRβ, using inverse agonists, or combining agents offers potential therapeutic avenues.
- Future strategies include targeting ABCA1, M2 macrophages, and LXRα phosphorylation.
Related Concept Videos
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Atherosclerosis I: Introduction
Cholesterol: Significance and Regulation
Considering cholesterol and...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...

